In the advanced stage of tumor progression and metastasis, TAMs usually favor the M2 phenotype, which is characterized by low expression of iNOS and IL-12, and high expression of CD206, Arg-1 and IL-10, promoting tissue repair and angiogenesis in favor of tumor progression [5, 6]. This evidence concerns the gene MRC1 and neoplasm.